ONE Finance Acquired by Hazel to Create All-in-One Fintech Platform
April 6, 2022
Cooley advised financial-services mobile app ONE Finance on its completed acquisition by Hazel, an independent fintech launched in partnership with Walmart and investment firm Ribbit Capital. Peter Werner and Luke Blackett led the Cooley team advising ONE.
Cooley advised Vera Therapeutics on its $47.85 million initial public offering of 4,350,000 shares of class A common stock. Vera Therapeutics, whose securities now trade on the Nasdaq Global Market under the symbol VERA, is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Partners Jodie Bourdet and Carlton Fleming led the Cooley team.
Cooley advised Spruce Biosciences on its $103.5 million initial public offering of 6,900,000 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. Spruce, whose securities now trade on the Nasdaq Global Select Market under the symbol “SPBR,” is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need. Partners Jason Kent and Kristin VanderPas led the Cooley team.